Search - tctmd.com

Displaying 1 - 20 of 67

Sort: Relevancy | Date

Presentation TCT 2025

TCT 100: Patented Automated Device for Removal of Contrast From Coronary Sinus for the Prevention of Contrast Induced Nephropathy During Coronary Angiography or Intervention

Presenter: Mohammad Reza Movahed

October 27, 2025

Presentation TCT 2024

TCT 332: Clinical and Financial Impact of an Automated vs. Manual Personal Contrast Calculator Tool to Prevent Contrast Nephropathy After Percutaneous Coronary Intervention

Presenter: Alan Zajarias

October 30, 2024

Presentation TCT 2024

TCT 327: Efficacy of High-Dose Statins on the Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization: Updated Systematic Review and Meta-Analysis

Presenter: Montaser Elkholy

October 30, 2024

Presentation Complex Coronary Cases 2023

Prevention of Contrast-Induced Nephropathy

Presenter: Shira Wender

June 16, 2023

Presentation TCT 2019

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

Presenter: Carlo Briguori

September 29, 2019

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Presentation TCT 2019

Your Cath Lab Needs a CIN Prevention Protocol: Here It Is!

Presenter: Hitinder Gurm

September 28, 2019

Presentation TCT 2019

CIN Prevention II: IV Fluids

Presenter: Carlo Briguori

September 28, 2019

CIN Prevention III: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presentation TCT 2019

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presenter: Ziad Ali

September 28, 2019

Presentation TCT 2019

CIN Risk Prediction and Outcomes

Presenter: Sripal Bangalore

September 28, 2019

Presentation TCT 2019

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

Presenter: Richard Solomon

September 28, 2019

Presentation TCT Abstracts Posters 2018

Advanced Practice Providers Utilize a Pre-Catheterization Screening Tool to Decrease Contrast Induced Nephropathy

Presenter: Jennifer K. McCullough

September 25, 2018

Presentation TCT Abstracts Posters 2018

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Presenter: Tamon Kato

September 25, 2018

Presentation TCT 2018

Topic 6: Radial Access and AKI- What Do We Know?

Presenter: Sripal Bangalore, Somjot S. Brar

September 23, 2018

Presentation TCT 2018

Topic 5: CIN Prevention Strategies

Presenter: Sripal Bangalore, Somjot S. Brar, Roxana Mehran

September 23, 2018

Presentation TCT 2018

Topic 4: CIN Risk Prediction and Outcomes

Presenter: Sripal Bangalore, Somjot S. Brar, Hitinder S. Gurm

September 23, 2018

Presentation TCT 2018

Topic 3: Revascularization Strategies (PCI, CABG) vs Medical Therapy in Advanced CKD

Presenter: Sripal Bangalore, Somjot S. Brar

September 23, 2018

Presentation TCT 2018

Topic 2: Zero Contrast PCI

Presenter: Sripal Bangalore, Somjot S. Brar, Ziad A. Ali

September 23, 2018

Presentation TCT 2018

Topic 1: Prognostic Significance of Acute Kidney Injury After TAVR

Presenter: Sripal Bangalore, Somjot S. Brar, Steven R. Bailey

September 23, 2018

Presentation TCT 2017

Acute Kidney Injury As a PCI Quality Improvement Metric: Strengths and Weaknesses

Presenter: Somjot S. Brar, Roxana Mehran, Hitinder S. Gurm

November 01, 2017

Advertisement

TCT 100: Patented Automated Device for Removal of Contrast From Coronary Sinus for the Prevention of Contrast Induced Nephropathy During Coronary Angiography or Intervention

TCT 332: Clinical and Financial Impact of an Automated vs. Manual Personal Contrast Calculator Tool to Prevent Contrast Nephropathy After Percutaneous Coronary Intervention

TCT 327: Efficacy of High-Dose Statins on the Prevention of Contrast-Induced Nephropathy After Cardiac Catheterization: Updated Systematic Review and Meta-Analysis

Prevention of Contrast-Induced Nephropathy

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Your Cath Lab Needs a CIN Prevention Protocol: Here It Is!

CIN Prevention II: IV Fluids

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

CIN Risk Prediction and Outcomes

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

Advanced Practice Providers Utilize a Pre-Catheterization Screening Tool to Decrease Contrast Induced Nephropathy

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Topic 6: Radial Access and AKI- What Do We Know?

Topic 5: CIN Prevention Strategies

Topic 4: CIN Risk Prediction and Outcomes

Topic 3: Revascularization Strategies (PCI, CABG) vs Medical Therapy in Advanced CKD

Topic 2: Zero Contrast PCI

Topic 1: Prognostic Significance of Acute Kidney Injury After TAVR

Acute Kidney Injury As a PCI Quality Improvement Metric: Strengths and Weaknesses

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content